Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1ALDESLEUKIN
(Interleukin-2)		[1] Aldesleukin (Interleukin-2 aldesleukin)[1] Aldesleukin (Interleukin-2) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[4] 49, 65, 96, 97 💬
2Anti-Human Interleukin-23 Monoclonal Antibody----[1] 271 💬
3Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Huma----[2] 96, 97 💬
4Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human----[2] 96, 97 💬
5Anti-Interleukin-23 Immunoglobulin G2 (IgG2) Human Monoclonal Antibody----[2] 96, 97 💬
6Human interleukin-2[1] Human interleukin-2---[1] 35 💬
7INTERLEUKIN-2[1] Human interleukin-2---[10] 2, 35, 49, 50, 53, 55, 65, 96, 97, 162 💬
8Interleukin-2 (aldesleukin).[2] Aldesleukin (Interleukin-2 aldesleukin),
Human interleukin-2		[1] Aldesleukin (Interleukin-2) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[2] 96, 97 💬
9Low-dose Aldesleukin (Proleukin®)
(Interleukin-2)		[1] Aldesleukin (Interleukin-2 aldesleukin)[1] Aldesleukin (Interleukin-2) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 49 💬
10Low-dose interleukin-2[1] Human interleukin-2---[1] 53 💬
11Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections[1] Human interleukin-2---[1] 2 💬
12PEG-interleukin-2[1] Human interleukin-2---[1] 65 💬
13Recombinant human interleukin-2[2] Aldesleukin (Interleukin-2 aldesleukin),
Human interleukin-2		[1] Aldesleukin (Interleukin-2) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 35 💬
14Recombinant human interleukin-2 (rhIL-2)[2] Aldesleukin (Interleukin-2 aldesleukin),
Human interleukin-2		[1] Aldesleukin (Interleukin-2) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 35 💬